Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

How to Get Arikayce (Amikacin Liposome Inhalation) Covered by Blue Cross Blue Shield in Virginia: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Arikayce Covered by Blue Cross Blue Shield in Virginia Arikayce (amikacin liposome inhalation) requires prior authorization from Blue Cross Blue Shield in Virginia for MAC lung disease. To get coverage, you need documented refractory MAC after 6+ months of standard multidrug therapy with persistent positive cultures. Submit

How to Get Ibrance (Palbociclib) Covered by Blue Cross Blue Shield in New Jersey: Complete PA Guide and Appeal Process

Answer Box: Getting Ibrance Covered in New Jersey Yes, Horizon Blue Cross Blue Shield of New Jersey covers Ibrance (palbociclib) for HR+/HER2- breast cancer, but prior authorization is required. The fastest path: (1) Have your oncologist submit PA documentation showing HR+/HER2- pathology, ECOG performance status 0-1, and combination

How to Get Evkeeza (Evinacumab) Covered by Blue Cross Blue Shield in New York: Coding, Appeals, and PA Requirements 2025

Answer Box: Quick Path to Evkeeza Coverage Getting Evkeeza (evinacumab-dgnb) covered by Blue Cross Blue Shield in New York requires three key steps: 1) Confirm your HoFH diagnosis with ICD-10 code E78.010 and genetic/clinical documentation, 2) Document failure or intolerance of maximum-dose statins, ezetimibe, and PCSK9 inhibitors, and

Myths vs. Facts: Getting Humira (adalimumab) Covered by Blue Cross Blue Shield in Illinois

Answer Box: Getting Humira Covered by BCBS Illinois The Reality: Blue Cross Blue Shield of Illinois requires prior authorization for Humira and strongly prefers biosimilars in 2025. Success depends on documenting biosimilar failure/intolerance and meeting specific clinical criteria. Fastest Path: 1) Check your plan's current formulary status,

Get Xospata (Gilteritinib) Covered by Blue Cross Blue Shield in Virginia: ICD-10 Codes, Prior Auth Forms, and Appeals Guide

Answer Box: Getting Xospata Covered in Virginia To get Xospata (gilteritinib) covered by Blue Cross Blue Shield in Virginia, you'll need: (1) confirmed FLT3-mutated relapsed/refractory AML diagnosis with proper ICD-10 coding (C92.02 for relapsed AML), (2) prior authorization submission through Anthem's Availity portal with

Do You Qualify for Opzelura (Ruxolitinib Cream) Coverage by Blue Cross Blue Shield in California? Decision Tree & Next Steps

Quick Answer: Getting Opzelura Covered by Blue Cross Blue Shield in California Yes, Opzelura (ruxolitinib cream) can be covered by Blue Cross Blue Shield plans in California, but prior authorization is required. You'll need documented failure of topical steroids or calcineurin inhibitors, confirmed diagnosis of atopic dermatitis or

How to Get Dojolvi (Triheptanoin) Covered by Blue Cross Blue Shield in Washington: Forms, Appeals, and Provider Resources

Quick Start: Getting Dojolvi Covered by Blue Cross Blue Shield in Washington Blue Cross Blue Shield plans in Washington (Premera Blue Cross, Regence BlueShield) require prior authorization for Dojolvi (triheptanoin) with molecular confirmation of long-chain fatty acid oxidation disorder (LC-FAOD). The fastest path: (1) Gather genetic test results confirming LC-FAOD

Do You Qualify for Tecentriq Coverage by Blue Cross Blue Shield in Washington? Decision Tree & Next Steps

Answer Box: Getting Tecentriq Covered by Blue Cross Blue Shield in Washington Yes, Blue Cross Blue Shield plans in Washington cover Tecentriq (atezolizumab) for FDA-approved indications, but prior authorization is required. Most approvals happen within 72 hours when you submit complete documentation. Your first step: Have your oncologist gather your

How Long Does It Take to Get Rylaze Approved by Blue Cross Blue Shield in Virginia? Complete Timeline & Appeal Guide

Answer Box: Getting Rylaze Covered by Blue Cross Blue Shield in Virginia Timeline: 1-3 business days for electronic prior authorization submissions; up to 7 days for Medicare members. Key requirement: Documentation of hypersensitivity to E. coli-derived asparaginase. First step: Have your oncologist submit PA through Anthem BCBS Virginia provider portal

How to Get Pomalyst (Pomalidomide) Covered by Blue Cross Blue Shield in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pomalyst Covered by Blue Cross Blue Shield in California Blue Cross Blue Shield California requires prior authorization for Pomalyst (pomalidomide). To get approved: (1) Ensure your oncologist documents progression after ≥2 prior therapies including lenalidomide and a proteasome inhibitor, (2) Complete REMS program enrollment for prescriber, patient,